Why It’s So Hard To Make Antiviral Drugs For COVID And Other Diseases-Scientific American

Physician Claudette Poole doesn’t take long to rattle off a list of antiviral medications she prescribes to her patients. “There really aren’t very many,” says Poole, a pediatric infectious disease physician at the University of Alabama at Birmingham. And for people with Covid-19, there’s just one approved for use: remdesivir, which doesn’t seem to save lives, but speeds recovery in those who do get well. Clearly, more antivirals would be nice to have—so why don’t we have them? Inventing them, it turns out, is not so easy. Scientific American, 02/11/2021

•   Print
•   Email
•   Share
•   Tweet